Navigation Links
QLT Inc. announces initial steps in strategic restructuring
Date:1/16/2008

ecuting our strategy," said Boyd Clarke, QLT's Chairman. "We look forward to working with our advisors and interested parties to maximize stockholder value," he added.

QLT plans to focus its ongoing business primarily on its Visudyne(R) franchise and its clinical development programs related to its punctal plug delivery technology and its photodynamic therapy dermatology technology. The Company expects to achieve the following milestones in these three areas as follows:

1) Visudyne: Completion of enrollment in the RADICAL combination study

with six-month results expected in Q4 2008.

2) Drug in Punctal Plugs for Glaucoma: IND filing for the punctal plug

with drug technology and initiation of a Phase I/II clinical trial

in glaucoma patients in H1, with results on plug retention and drug

elution expected by year end 2008.

3) Photodynamic therapy with Lemuteporfin (QLT00748): Human proof-of-

concept studies for the treatment of moderate to severe acne

expected to be completed in 2008.

The Company expects to gain further insight into the strategic value of these assets as clinical milestones are met. The Board of Directors will continue to evaluate strategic options regarding these assets as they progress through their clinical development.

"I look forward to increasing our operational efficiency and driving our business forward with a clear focus on these three key programs," commented Bob Butchofsky, President and Chief Executive Officer. "We are focused on achieving these important clinical milestones and are excited about their potential to create significant shareholder value."

About QLT

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Our research and development efforts are focused on pharmaceutical products in the fields of ophthalmology and
'/>"/>

SOURCE QLT Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... A Priority Setting Partnership put ... ten list they hope will guide future mesothelioma research. Surviving Mesothelioma has just ... , More than 450 mesothelioma patients, caregivers, and healthcare professionals answer ...
(Date:7/1/2015)... ... ... Francesca Camp wasn’t always a steadfast supporter of plastic surgery. But just as ... the practice; a terrible car accident years ago left her injured and in need of ... ? (And What if I Do?): Answers to All Your Questions about Plastic Surgery” (published ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... firm B. E. Smith, Tri-City Medical Center in Oceanside, Calif., has ... proven record of leading organization-wide compliance adaptation efforts and growing a focus on ...
(Date:7/1/2015)... ... 01, 2015 , ... Incentivizing the use of generic drugs has been an ... as 80% or 90% off the prices for the brand-name products. But now that ... the financial impact of these high-cost generic drugs. The July issue of Atlantic Information ...
(Date:7/1/2015)... CA (PRWEB) , ... July 01, 2015 , ... ... returned to the Northbound team as Director of Referral Relations. , Emily ... including Northbound’s Collegebound, where she designed and implemented unique academic curriculum for clients ...
Breaking Medicine News(10 mins):Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2
... Inc., (Nasdaq: IDIX ) announced today that it ... 2008 on Tuesday, April 29,2008 before the U.S. financial ... the press release, Idenix,management will host a conference call ... discuss the company,s financial results for the first quarter,2008., ...
... to patients remains very low, expert says , , THURSDAY, April ... at an increased risk for stroke compared to those with ... the other hand, those with less frequent migraines may have ... researchers report. , The findings, to be presented Thursday ...
... (Nasdaq: DYNT ) today announced the introduction ... for treating back pain and the,Dynatron X5 "Turbo" ... Spinal Health System uses a four-phase treatment,regimen combining ... and nutrition," said Larry K. Beardall,executive vice president ...
... EAGAN, Minn., April 17 Blue Cross and Blue ... for 2007. The,company reported an overall net gain of ... with $7.7 billion in medical claims,costs. Investment income offset ... with statutory reserves equal to nearly,three months of claims ...
... CHICAGO, April 17 Heavy drinkers and heavy,smokers ... who do not drink or smoke heavily, according ... Academy of Neurology 60th Anniversary,Annual Meeting in Chicago, ... because it,s possible that if we can,reduce or ...
... MD, DrPH, Anna Cheskis Gelman and Murray Charles Gelman ... the Mailman School of Public Health and professor of ... 2008 Distinguished Investigator Award from NARSAD, the world,s leading ... Susser was selected for a study on famine and ...
Cached Medicine News:Health News:Migraines' Frequency Influences Heart Attack, Stroke Risk 2Health News:Migraines' Frequency Influences Heart Attack, Stroke Risk 3Health News:Dynatronics Introduces New DynaPro Spinal Health System and X5 'Turbo' 2Health News:Blue Cross and Blue Shield of Minnesota Releases 2007 Financial Results 2Health News:Alzheimer's Starts Earlier for Heavy Drinkers, Smokers 2Health News:Ezra Susser, MD, DrPH, receives Distinguished Investigator Award from NARSAD 2
(Date:7/1/2015)... 1, 2015  Unilife Corporation (NASDAQ: UNIS ... injectable drug delivery systems, announced today that its debt ... 30, 2015. This amendment removed a covenant that required ... receipts from customers during the six months ended June ... of the terms of the debt agreement as part ...
(Date:7/1/2015)... HEIGHTS, Utah , July 1, 2015 /PRNewswire/ ... ), a manufacturer and marketer of rehabilitation and ... completed its $4,025,000 private placement financing led by ... strategic private equity investor focused on the healthcare ... to promote organic growth and pursue potential strategic ...
(Date:7/1/2015)... 1, 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of proprietary compounded drug formulations, ... Nasdaq stock market closing bell on Thursday, July ... of its Go Dropless™ campaign since its launch ... are performed annually in the U.S. and more ...
Breaking Medicine Technology:Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... 2, 2010 Fiscal first quarter revenue from ... $641 million Fiscal first quarter adjusted income from ... $0.87 per share Fiscal first quarter GAAP income ... per share Rx segment revenue grew 47 percent ...
... IRVINE, Calif., Nov. 2, 2010 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today the first clinical implant ... City Hospital in Auckland, New Zealand.  The procedure was ... of Interventional Radiology) and Andrew, Hill, MD (Associate Professor ...
Cached Medicine Technology:Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 2Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 3Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 4Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 5Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 6Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 7Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 8Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 9Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 10Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 11Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 12Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 13Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 14Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 15Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 16Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 17Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 18Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 19Endologix Announces First Clinical Implant of Ventana™ Stent Graft 2Endologix Announces First Clinical Implant of Ventana™ Stent Graft 3Endologix Announces First Clinical Implant of Ventana™ Stent Graft 4
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: